Muscle protein Miro1 may drive insulin resistance, revealing potential type 2 diabetes treatment target
A protein called Miro1, found at elevated levels in the skeletal muscle of people with type 2 diabetes, may contribute to insulin resistance, potentially making it a target for future treatments that help the body regulate blood sugar, according to a study published in Nature Communications.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Increased risk-taking behavior precedes higher alcohol consumption, study finds
United Kingdom
-
For caregivers with cardiovascular conditions, poor sleep and emotional distress are linked to greater strain
United Kingdom
-
Researchers use mitochondrial uncouplers to target breast cancer metastasis
United Kingdom
-
Blood pressure drug losartan boosts metabolism by stimulating brown fat
United Kingdom
-
UCL study reveals broad mortality risks faced by ADHD individuals
United Kingdom
-
Study identifies initial cellular events in autoimmune kidney inflammation
United Kingdom
-
Severe distress after trauma does not always mean lasting harm, new study finds
United Kingdom
-
Vaccination has little impact on post-COVID smell and taste issues, study shows
United Kingdom